Alvotech stated that it designed the study to evaluate the safety, tolerability, and immunogenicity profiles of AVT80 and ...

AbbVie Inc. targets $38B in Skyrizi and Rinvoq sales by 2030, a 3% dividend yield, and 7.7% EPS growth via acquisitions.

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts ...

Reducing pembrolizumab infusions from 30 minutes to 10 minutes could be a safe alternative for patients and open hundreds of ...